News | 4BIO Capital

NEWSROOM

Nov 18

4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy

Nov 14

4BIO Capital Becomes First UK Venture Fund Certified by Japan's AMED

Nov 4

4BIO Capital Strengthens Investment Team

Oct 28

ViaNautis Bio Signs Strategic Collaboration Agreement with Lilly

Oct 23

4BIO Capital leads oversubscribed $28.4 million Series A financing of March Biosciences

Oct 18

ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer